Cleared Traditional

K894045 - MODIFIED POLYCHROME IV STAIN

K894045 is an FDA 510(k) clearance for MODIFIED POLYCHROME IV STAIN, manufactured by Devetec, Inc.. The device is a Class 1 Pathology device with product code KFD cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K894045 · Devetec, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1989
Decision
48d
Days
Class 1
Risk

K894045 is an FDA 510(k) clearance for the MODIFIED POLYCHROME IV STAIN. Classified as Aniline Blue (product code KFD), Class I - General Controls.

Submitted by Devetec, Inc. (Bradenton, US). The FDA issued a Cleared decision on July 25, 1989 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.1850 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K894045

510(k) Number K894045 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 1989
Decision Date July 25, 1989
Days to Decision 48 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 78d · This submission: 48d
Pathway characteristics
Predicate-based equivalence.

KFD Device Classification - Class 1, General Controls

Product Code KFD Aniline Blue
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.1850
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.